- Investigator
- Mohammad Ilyas
- Ages
- 0 Years - 12 Years
- Sexes
- All
Clinical trials
-
Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia